Prognostic factors of overall survival for Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy

QU Yuan-yuan,DAI Bo,KONG Yun-yi,YE Ding-wei,YAO Xu-dong,ZHANG Shi-lin,ZHANG Hai-liang,MA Chun-guang

DOI: https://doi.org/10.3969/j.issn.1007-3969.2012.10.012

2012-01-01

Abstract:Background and purpose:The prognostic factors for patients with metastatic castration-resistant prostate cancer(mCRPC) treated with docetaxel-based chemotherapy is still controversial.We aimed to evaluate the potential value of patient characteristics before the onset of chemotherapy to predict overall survival(OS) in Chinese patients.Methods:We retrospectively analyzed the data of 115 consecutive Chinese patients with mCRPC received docetaxel chemotherapy in our institution from Nov.2005 to Sep.2011.All 115 patients have bone metastasis,and 16 cases were simultaneously observed to have the presence of visceral metastasis including lung(9 cases),bladder(4 cases),liver(2 cases) and brain(1 case).The average cycles of chemotherapy was 6 ranging from 1 to 16.We retrospectively collected the variables including patient characteristics at diagnosis(age,serum PSA level,Gleason score) and characteristics before the start of chemotherapy(age,serum PSA level,complete blood count,hemoglobin(Hb) concentration,albumin concentration,bone and(or) visceral metastasis,Eastern Cooperative Oncology Group performance status(ECOG PS),cycles of chemotherapy and time to castration resistance).All laboratory analyses were performed in the same laboratory.Survival analysis was performed using Kaplan–Meier curves,and the differences in overall survival rates were assessed using the log-rank test.Only variables that were statistically significant in the univariate analysis(P<0.05) were included in the multivariate model.Results:The follow-up was performed until April 30,2012,and median follow-up time was 45.0 months,ranging from 2.0 to 74.0 months.During the follow-up period,87 of 115 patients(75.7%) died and the median OS for the entire cohort was 17.0 months,ranging from 2.0 to 46.0 months.The univariate analysis identified a total of 5 statistically significant predictors of OS: baseline serum PSA level,baseline Hb concentration,ECOG PS,cycles of chemotherapy,and time to castration resistance.Subsequent multivariate analysis reserved baseline Hb concentration and cycles of chemotherapy as independent prognostic factors for OS.Median OS for patients with baseline Hb concentration<110 g/L and ≥110 g/L were(12.0±2.2) months and(20.0±2.3) months,respectively(P=0.003).Median OS for patients with cycles of chemotherapy<6 and ≥6 were(12.0±1.2) months and(24.0±5.1) months,respectively(P<0.001).Conclusion:This retrospective analysis has demonstrated that baseline Hb concentration and cycles of chemotherapy could provide independent prognostic information of OS in Chinese patients with mCRPC treated with docetaxel.They can be used to optimize management of mCRPC.